Erectile dysfunction (ED) is defined as “the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance.” Hyperbaric oxygen therapy (HBOT) has been shown to aid in the vecovery of erectile dysfunction.
Erectile dysfunction is a global health problem that has a negative impact on a man’s quality of life which most commonly affects men from the age of 40. Oral suspensions are the most popular over-the-counter treatments, followed by injections and surgical treatment. However recent research into the effects of hyperbaric oxygen therapy (HBOT) on erectile dysfunction has proved very promising with numerous success stories.
The narrowing of blood vessels is usually to blame for erectile dysfunction, but recent studies have shown that HBOT can induce tissue oxygenation and angiogenesis (the formation of new blood vessels) in body tissue and has a positive impact on the recovery of erectile functions after urethral reconstruction.
In these studies most erectile functions were improved except for orgasmic function and testosterone levels. Research by Amir Hadanny MD was published in 2018 stating that “HBOT can induce penile angiogenesis and improve erectile function in men suffering from erectile dysfunction. HBOT reverses the basic common pathophysiology, atherosclerosis and decreased penile perfusion which are all responsible for most erectile dysfunction cases. The treatment can even be considered years after the onset of erectile dysfunction and in men with an unsatisfactory response to pharmacotherapy.”
HybO2 offers a range of chambers for use at home or at our clinic in Winchester. We also supply chambers to clinics and health centres around the world. Please get in touch if you would like more information.
To read more follow https://pubmed.ncbi.nlm.nih.gov/30089290/
